Cure My Disease

Don't miss your cure!

 Log in / Sign up

New MS drug safety checked in asian patients

NCT ID NCT05083923

Completed Disease control Sponsor: Biogen Source: ClinicalTrials.gov ↗

Summary

This study tested the safety and how the body processes the drug diroximel fumarate in adults with relapsing forms of multiple sclerosis (MS) from the Asia-Pacific region. It involved 136 participants who took the drug for either 24 or 48 weeks. The main goal was to see how well the drug was tolerated and to measure its levels in the blood, not to test how well it controls MS symptoms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING FORMS OF MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Beijing Hospital

    Beijing, Beijing Municipality, 100006, China

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100050, China

  • Chiba University Hospital

    Chiba, Chiba, 260-8677, Japan

  • Department of Neurosurgery, Tokyo Women's Medical University

    Shinjuku-ku, Tokyo-To, 162-8666, Japan

  • Dongguan People's Hospital

    Dongguan, Guangdong, 523059, China

  • Ebara Hospital

    Ōta-ku, Tokyo-To, 145-0065, Japan

  • Ehime University Hospital

    Toon-shi, Ehime, 791-0295, Japan

  • First Affiliated Hospital of Kunming Medical University

    Kunming, Yun'nan, 650032, China

  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, 350001, China

  • Fukuoka University Hospital

    Fukuoka, Fukuoka, 814-0180, Japan

  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia Hui, 750004, China

  • Guangzhou First People's Hospital

    Guangzhou, Guangdong, 510180, China

  • Hospital of the University of Occupational and Environmental Health

    Kitakyushu-shi, Fukuoka, 807-8556, Japan

  • Iwate Medical University Uchimaru Medical Center

    Morioka, Iwate, 020-8505, Japan

  • Jiangxi Provincial People's Hospital

    Nanchang, Jiangxi, 330006, China

  • Juntendo University Hospital

    Bunkyō City, Tokyo-To, 113-8431, Japan

  • Kansai Medical University Medical Center

    Moriguchi-shi, Osaka, 570-8507, Japan

  • Lanzhou University Second Hospital

    Lanzhou, Gansu, 730030, China

  • NHO Asahikawa Medical Center

    Asahikawa-shi, Hokkaido, 070-8644, Japan

  • NHO Hokkaido Medical Center

    Sapporo, Hokkaido, 063-0005, Japan

  • Nanfang Hospital of Southern Medical University

    Guangzhou, Guangdong, 510515, China

  • National Center of Neurology and Psychiatry

    Kodaira-shi, Tokyo-To, 187-8551, Japan

  • Niigata University Medical & Dental Hospital

    Niigata, Niigata, 951-8520, Japan

  • Obihiro Kosei Hospital

    Obihiro, Hokkaido, 080-0024, Japan

  • Renji Hospital Shanghai Jiaotong University School of Medicine - West Branch

    Shanghai, Shanghai Municipality, 200001, China

  • Saitama Medical Center

    Kawagoe-shi, Saitama, 350-8550, Japan

  • Shanxi Provincial People's Hospital

    Taiyuan, Shanxi, 30012, China

  • Shengjing Hospital of China Medical University

    Shengyang, Liaoning, 110004, China

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, 610072, China

  • Southern Tohoku Medical Clinic

    Koriyama-shi, Fukushima, 963-8563, Japan

  • Tangdu Hospital, Fourth Military Medical University

    Xi'an, Shan'xi, 710038, China

  • Tangshan Gongren Hospital

    Tangshan, Hebei, 063003, China

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, 10050, China

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, 230022, China

  • The First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150040, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330006, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, 215004, China

  • The First Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510080, China

  • The First Hospital of Jilin University

    Changchun, Jilin, 130021, China

  • The Second Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, 510260, China

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150086, China

  • The Third Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510630, China

  • Tianjin Medical University Affiliated General Hospital

    Tianjin, Tianjin Municipality, 300052, China

  • Tohoku Medical and Pharmaceutical University Hospital

    Sendai, Miyagi, 983-8512, Japan

  • Tohoku University Hospital

    Sendai, Miyagi, 980-8574, Japan

  • Tokyo Womens Medical University Yachiyo Medical Center

    Yachiyo, Chiba, 276-8524, Japan

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology

    Wuhan, Hubei, 430030, China

  • University of Tsukuba Hospital

    Tsukuba, Ibaraki, 305-8576, Japan

  • Wakayama Medical University Hospital

    Wakayama, Wakayama, 641-8510, Japan

  • Xiangya Hospital, Central South University

    Changsha, Hu'nan, 410008, China

  • Yamaguchi University Hospital

    Ube-shi, Yamaguchi, 755-8505, Japan

  • Yokohama City University Hospital

    Yokohama, Kanagawa, 236-0004, Japan

Conditions

Explore the condition pages connected to this study.

RELAPSING FORMS OF MULTIPLE SCLEROSIS